In 2018, Chinese biophysicist He Jiankui engaged in gene-hacking experiments using CRISPR technology. He used it to edit the ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI ...

New gene-editing therapy shows early success in fighting advanced GI cancers. ScienceDaily . Retrieved May 28, 2025 from www.sciencedaily.com / releases / 2025 / 05 / 250502133947.htm ...

DURHAM, N.C., May 01, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo ...

By inserting an entire gene, the tool offers a one-and-done approach that overcomes hurdles from CRISPR gene editing technology—which is programmed to correct individual mutations—offering a ...

All of this has resulted in a sour business mood, and a number of gene-editing therapy companies are struggling to stay afloat. Some have dramatically narrowed their pipelines and laid off staff.

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes referred to as “the next big thing in agriculture.” The important ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms ...

You can reach Jason on Signal at JasonMast.05. SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling ...

The physical structure of OpenCRISPR-1, a gene editor created by A.I. technology from Profluent.Credit...Video by Profluent Bio Supported by By Cade Metz Has reported on the intersection of A.I ...

Gene editing stocks have received a lot of attention ... The other approved therapy was developed by Bluebird Bio (NASDAQ:BLUE). However, The label for bluebird bio’s treatment included a ...